Bernstein Karen 4
4 · Ovid Therapeutics Inc. · Filed Dec 16, 2024
Insider Transaction Report
Form 4
Bernstein Karen
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-12-12+90,000→ 90,000 totalExercise: $1.06Exp: 2034-12-11→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]The shares will vest in 36 equal monthly installments, subject to the Reporting Person's continued services through such date.